Hearing Review TV Episode 12


Uploaded by hrpalliedmedia on 12.04.2011

Transcript:
Hello and welcome
to today's episode of
Hearing Review TV
your all access pass
to all things hearing.
Today's episode is brought to you
by the Audigy Group
the pre-eminent group of hearing providers
in North America.
I'm Jon Daugharthy.
The screening of newborns
for hearing loss
appears to be working
but a new study shows
nearly 1/3 of children
who have cochlear implants
pass their newborn screening.
In Illinois,
universal newborn hearing screening
was mandated in 2003
for all birthing hospitals.
In the study
doctors from
Children's Memorial Hospital in Chicago
examined data for 391 children
with cochlear implants.
Those patients were divided into
those born before
the mandatory screening
went into effect
and those who were born
after the screening became
legally required.
As you can see,
children born after
the law went into effect
were screened at
a much higher rate
than those born before.
Of the children born
after the mandate,
more than 80
had at least one
risk factor for hearing loss
and 21 of them
passed the screening.
The researchers concluded
that delayed onset of hearing loss
limits the ability to achieve
early diagnosis and implantation
of a significant number
of deaf children.
The complete article is in the
March issue of the
JAMA Journal
Archives of Otolaryngology-Head and Neck Surgery.
Several states are considering
new laws that ban mercury
powered batteries for hearing aids
and three already have similar
laws on the books.
And Renata Batteries has developed
a new line of 0%
silver oxide button cell batteries
to meet the new demand.
On July 1st, 2011
it will be illegal to sell
button cell batteries that have mercury
in Connecticut, Rhode Island
and Maine.
This comes after the
National Electrical Manufacturers Association
announced its commitment to eliminate
mercury from button cell batteries
by the end of this June.
30 other states have also enacted
or are proposing regulations
addressing the use of mercury
in hearing aid batteries.
Rayovac and Energizer
currently have a line of
mercury-free batteries.
Zeni-Power battery company
will also reportedly have
mercury-free batteries
by mid to late 2011.
And, Varta Batteries' Power One
has mercury-free rechargeable
hearing aid batteries.
The X-Factor
it's that something x-tra
you get when working for an
Audigy-certified practice.
You'll have a career
not just a job.
You'll receive support
from an expert team
of experienced professionals
investment in your continuing education
and professional growth
and, access to state-of-the-art
practice platforms
and cutting edge technology
Realize your personal,
professional, and financial goals.
Visit Audigy Group at
www.AudigyGroup.com.
Discover the power the x-factor has in store for you!
Better hearing could be just a few clicks away.
The American Hearing Aid Associates
has launched "SecondSenseHearing.com"
it's a new website that provides
people with hearing loss
and their families' key information
about causes and types of hearing loss.
The site will also have information
on the latest technology designed
to improve quality of life.
And, visitors will be able to access
AHAA's database of certified audiologists
to find a specialist in their area.
The group says its goal is for
"SecondSenseHearing.com" is to be the first place
consumers go to learn about
hearing healthcare solutions.
The balance assessment brand of
GN Otometrics hits a big milestone this year.
ICS Medical celebrates its 30th anniversary
in 2011 and will mark the occasion
with a year-long celebration focusing on
its history and new product launches.
In 1981, ICS Medical broke new ground
in balance testing with the
1st commercial computer based system for ENG.
The company was the first to integrate
computer-controlled optical and caloric stimuli
with the recording and analysis system.
It also launched "CHARTR" in 1999
the first windows based system
that combined VNG and ENG.
GN Otometrics acquired ICS Medical in 2000
and since then
has released two upgrades to the CHARTR
system with the partnership
of Dr. Kamran Barin.
This year,
Otometrics will celebrate
the 30 years of ICS
starting with this year's
AAA show in Chicago,
April 6th through the 9th.
Dr. Barin will be there
and make several exclusive presentations
at the Otometrics booth.
Siemens Hearing Instruments has a new leader.
The New Jersey company
announced that Scott Davis
has assumed the role of acting
CEO of Siemens Hearing Instruments
in the United States.
For the last year,
Davis has worked with the
Siemens Audiology Group on several strategic
initiatives to enhance customer service
and improve operational performance.
Davis replaces Brian Kinnerk
who was appointed CEO in January 2010.
Resound has solid news to report
on its nanotech protective coating.
It found the iSolate coating
significantly reduces moisture
related hearing aid repairs.
Resound says in a review of
50,000 hearing aids sold,
the iSolate coating was shown
to decrease moisture and
debris related repairs by
50% in the first six months.
Jennifer Groth is with the global audiology
department of Resound.
She says the benefits of
iSolate should become more evident with time
and that they expect even better
results at the nine-to-twelve month mark.
ISolate works by coating all elements
of the hearing aid with a thin protective layer
that bonds at a molecular level
with all the components.
If any liquids come into contact
with the hearing aid,
they just roll off
without being absorbed.
15-year-old recommendations
will remain in place for
a while longer.
The US Preventive Services Task Force
recently reviewed evidence on screening
in primary care settings
in adults age 50 and over
for hearing loss.
The group wanted to know
if screening improves results
for these patients.
Researchers looked at randomized trials,
controlled observational studies,
studies on diagnostic accuracy,
and the evidence on benefits
and harms of screening for hearing loss.
They found no evidence that
screening for hearing loss
had any negative health effects.
They also found that hearing aid
use does not lead to further hearing loss
to increased amplification.
The researchers say more study
is needed before they can recommend changes
to the 1996 report.
For more information,
look in the February 28th issue
of the Annals of Internal Medicine.
That's all we have for today's episode of
Hearing Review TV
brought to you by
the Audigy Group.
We'll see you next time.